129 related articles for article (PubMed ID: 3855385)
1. Phase II trial of 4'-epi-doxorubicin in advanced colorectal carcinoma: a Northern California Oncology Group study.
Meyers FJ; Lewis B; Mitchell E; William L; Hannigan JF; Gribble M; Torti FM
Cancer Treat Rep; 1985 Jan; 69(1):143-4. PubMed ID: 3855385
[No Abstract] [Full Text] [Related]
2. Phase II study of esorubicin in patients with advanced colorectal carcinoma and no prior chemotherapy: an Illinois Cancer Council Trial.
Locker GY; Hoeltgen T; Kilton L; Krauss S; McNamara M; Blough R; Johnson C
Cancer Treat Rep; 1987; 71(7-8):765-6. PubMed ID: 3300969
[No Abstract] [Full Text] [Related]
3. Phase II evaluation of 4'-epi-doxorubicin in patients with advanced colorectal carcinoma.
Michaelson R; Kemeny N; Young C
Cancer Treat Rep; 1982 Sep; 66(9):1757-8. PubMed ID: 6956441
[TBL] [Abstract][Full Text] [Related]
4. Phase II evaluation of 4'-epi-doxorubicin in patients with metastatic colorectal carcinoma.
Ajani JA; Kanojia MD; Bodey GP
Cancer Treat Rep; 1984 Dec; 68(12):1507-8. PubMed ID: 6595058
[No Abstract] [Full Text] [Related]
5. Phase II trial of esorubicin in patients with advanced colorectal carcinoma.
Fiore J; Kemeny N; Raymond V; Young C
Cancer Treat Rep; 1986 Oct; 70(10):1241-2. PubMed ID: 3530453
[No Abstract] [Full Text] [Related]
6. Phase II trial of 4'-epi-doxorubicin in advanced carcinoma of head and neck origin.
Magee MJ; Howard J; Bosl GJ; Wittes RE
Cancer Treat Rep; 1985 Jan; 69(1):125-6. PubMed ID: 3855384
[TBL] [Abstract][Full Text] [Related]
7. Phase II trial of esorubicin in the treatment of metastatic carcinoma of the kidney: a study of the Northern California Oncology Group.
Carlson RW; Williams RD; Billingham ME; Kohler M; Torti FM
Cancer Treat Rep; 1987; 71(7-8):767-8. PubMed ID: 3607787
[No Abstract] [Full Text] [Related]
8. Phase II trial of bisantrene in advanced colorectal carcinoma.
Ahmed T; Kemeny NE; Michaelson RA; Harper HD
Cancer Treat Rep; 1983 Mar; 67(3):307-8. PubMed ID: 6831479
[No Abstract] [Full Text] [Related]
9. Phase II trial of 4-demethoxydaunorubicin in advanced colorectal carcinoma.
Harper HD; Kemeny NE; Ahmed T; Cheng E; Arena F; Sordillo P; Faye L
Cancer Treat Rep; 1984 Apr; 68(4):689-90. PubMed ID: 6585273
[No Abstract] [Full Text] [Related]
10. Phase II trial: mitomycin c and methotrexate combination therapy for advanced colorectal carcinoma.
Budman DR; Schulman P; Vinciguerra V; Degnan T
Cancer Treat Rep; 1981; 65(5-6):535. PubMed ID: 7237477
[No Abstract] [Full Text] [Related]
11. Phase II trial of 4'-epi-doxorubicin in patients with non-small cell lung cancer.
Kalman LA; Kris MG; Gralla RJ; Kelsen DP; Casper ES; Heelan RT; Wittes RE
Cancer Treat Rep; 1983 Jun; 67(6):591-2. PubMed ID: 6574820
[No Abstract] [Full Text] [Related]
12. Phase II trial of mitoxantrone in previously untreated patients with colorectal adenocarcinoma: A Southwest Oncology Group Study.
Cowan JD; Von Hoff DD; McDonald B; Talley RW; McCracken JD; Chen T
Cancer Treat Rep; 1982 Sep; 66(9):1779-80. PubMed ID: 7116355
[No Abstract] [Full Text] [Related]
13. Phase II evaluation of metoprine in patients with advanced colorectal carcinoma.
Lynch G; Kemeny N; Currie V
Cancer Treat Rep; 1981; 65(1-2):127-8. PubMed ID: 7226162
[No Abstract] [Full Text] [Related]
14. Phase II trial of 4'-epi-doxorubicin in metastatic colorectal carcinoma.
Wils JA
Invest New Drugs; 1984; 2(4):397-9. PubMed ID: 6595243
[TBL] [Abstract][Full Text] [Related]
15. Phase II evaluation of pyrazofurin in patients with advanced colorectal carcinoma.
Carroll DS; Kemeny NE; Gralla RJ
Cancer Treat Rep; 1979 Jan; 63(1):139-40. PubMed ID: 369686
[No Abstract] [Full Text] [Related]
16. Phase II evaluation of metoprine with leucovorin rescue in patients with advanced colorectal carcinoma.
Lynch G; Currie V; Kemeny N
Cancer Clin Trials; 1981; 4(3):281-3. PubMed ID: 6974612
[TBL] [Abstract][Full Text] [Related]
17. Phase II study on oral N-methylformamide in metastatic colorectal cancer.
Planting AS; Klijn JG; Verweij J; Stoter G
Cancer Treat Rep; 1987 Dec; 71(12):1293-4. PubMed ID: 3690540
[No Abstract] [Full Text] [Related]
18. Phase II study of ftorafur in previously untreated and treated patients with advanced colorectal cancer.
Schutt AJ; Hahn RG; Moertel CG; O'Connell MJ; Rubin J; Creagan ET
Cancer Treat Rep; 1983 May; 67(5):505-6. PubMed ID: 6406062
[No Abstract] [Full Text] [Related]
19. Phase II clinical trial of tricyclic nucleoside phosphate for advanced colorectal cancer.
O'Connell MJ; Rubin J; Hahn RG; Kvols LK; Moertel CG
Cancer Treat Rep; 1987 Mar; 71(3):333-4. PubMed ID: 3815402
[No Abstract] [Full Text] [Related]
20. Phase II trial of 4'-epi-doxorubicin in patients with advanced malignant melanoma.
Berman E; Casper ES; Howard J; Wittes RE
Cancer Treat Rep; 1984 Apr; 68(4):679-80. PubMed ID: 6585272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]